Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential.
- Published In:
- Archives of microbiology, 208(4), 192 (2026)
- Database ID:
- RPEP-15728
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15728APA
Mohammadzadeh Rostami, Farzaneh; Shalibeik, Saman. (2026). Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential.. Archives of microbiology, 208(4), 192. https://doi.org/10.1007/s00203-026-04731-x
MLA
Mohammadzadeh Rostami, Farzaneh, et al. "Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential.." Archives of microbiology, 2026. https://doi.org/10.1007/s00203-026-04731-x
RethinkPeptides
RethinkPeptides Research Database. "Selective cytotoxicity of microcin H47 against MDA-MB-231 br..." RPEP-15728. Retrieved from https://rethinkpeptides.com/research/mohammadzadeh-2026-selective-cytotoxicity-of-microcin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.